Syros Pharmaceuticals, Inc.401(k)
SYROS PHARMACEUTICALS, INC. 401(K) PLAN · CAMBRIDGE, MA · plan year 2023
Peer grade: A- · admin costs + employer contributions vs same-size plans · how grading works
Syros Pharmaceuticals, Inc. reported $35,387 in plan administrative expenses for 2023: 0.25% of average plan assets, below the peer median. Employer contributions averaged $13,754 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 2 years on file its reported administrative ratio rose from 0.24% to 0.47%. The plan sits in the $10M–$50M size bracket, benchmarked here against 26,779 comparable plans and shown alongside other manufacturing employers. By assets it is among the smaller plans on file in Massachusetts (1,496th of 2,726), and the 6,765th of 13,661 in manufacturing. In 2023, employees put in $2.29 for every $1.00 the employer contributed; active participation has shrunk from 116 to 68 since 2022.
Syros Pharmaceuticals, Inc.'s 2023 employer contribution ran above the $2,440 median for plans its size, placing it in the top quarter of its peers. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2023 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 453772460 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.